To settle this controversy, DeLeeuw et al. [10] made great efforts in meta-analyzing the prognostic significance of Foxp3+ TILs across 16 non-lymphoid cancers by enrolling 58 studies. This evidence concerns the gene FOXP3 and lymphoma.